UNDERWRITING AGREEMENT between MAIA BIOTECHNOLOGY, INC. and THINKEQUITY LLC as Representative of the Several UnderwritersUnderwriting Agreement • December 22nd, 2021 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • New York
The undersigned, MAIA Biotechnology, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of MAIA Biotechnology, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”). To the extent there are no additional underwriters named in Schedule I hereto other than you, the term Representative as used herein shall mean you, as Underwriter, and the terms “Representative” and “Underwriter” shall mean either the s
INDEMNITY AGREEMENTIndemnification Agreement • December 22nd, 2021 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of ___________ ____, 2021, is made by and between MAIA BIOTECHNOLOGY, INC., a Delaware corporation (the “Company”), and _________________ (“Indemnitee”), and will become effective upon the closing of the Company’s initial public offering.
Original Agreement: December 1, 2019 Amended Agreement: March 29, 2020 2nd Amended Agreement: November 1, 2020 3rd Amended Agreement: Effective date when $12M Qualified Funds Raised is ReachedExecutive Employment Agreement • December 22nd, 2021 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Illinois
Original Agreement: July 26, 2021 Amended Agreement: Effective date when $12M Qualified Funds Raised is ReachedExecutive Employment Agreement • December 22nd, 2021 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Illinois
